Summary:
- The Indian government has reduced the Goods and Services Tax (GST) on three anti-cancer drugs from 12% to 5%, months after waiving the import duty on these drugs.
- The move is aimed at making these life-saving drugs more affordable for cancer patients in India, where the cost of cancer treatment is a significant burden.
- However, experts suggest that the GST reduction alone may not provide substantial relief, and the government should consider further policy interventions to ensure greater accessibility and affordability of these drugs.